Provided by Tiger Fintech (Singapore) Pte. Ltd.

TuHURA Biosciences, Inc.

2.22
-0.0700-3.06%
Post-market: 2.220.00000.00%19:34 EDT
Volume:2.95M
Turnover:6.54M
Market Cap:96.97M
PE:-2.40
High:2.36
Open:2.29
Low:2.10
Close:2.29
Loading ...
Jun 27, 2025

Major Issues Report

Form 8-K - Current report
Jun 24, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 24, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

Major Issues Report

Form 8-K - Current report
Jun 06, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 16, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 16, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 08, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 07, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 07, 2025

Major Issues Report

Form 8-K - Current report
May 05, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 28, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 08, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 01, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]